Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Bausch Health Companies Inc T.BHC

Alternate Symbol(s):  BHC

Healthcare
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:BHC)

The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis

Accesswire November 10, 2023

CORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis

Accesswire November 10, 2023

As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)

Accesswire November 8, 2023

Bausch Health Announces Third-Quarter 2023 Results

Accesswire November 2, 2023

U.S. District Court Dismisses Norwich's Lawsuit Against the FDA

Accesswire November 1, 2023

Canadian Investment Regulatory Organization Trade Resumption - BHC

Canada NewsWire November 1, 2023

Canadian Investment Regulatory Organization Trading Halt - BHC

Canada NewsWire November 1, 2023

Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)

Accesswire October 26, 2023

FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older

Accesswire October 20, 2023
View More News ››

Opinion & Analysis (TSX:BHC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:BHC)

Record Q3 revenue for CEMATRIX

Pharmaceutical companies are great investments long term but I bet many of you investors are looking for that 10 bagger. Here it is...
kingscorpion - November 8, 2023

Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)

LAVAL, QC / ACCESSWIRE / June 30, 2023 / Bausch + Lomb Corporation (NYSE/TSX:BLCO), a subsidiary of Bausch Health Companies Inc...
Betteryear2 - June 30, 2023

Massive Short Squeeze Coming on RHT. Don't miss this...

Short interest increased on Reliq Health Technologies right when the company is breaking out. 1st Quarter financial update out in a week....
SqueezePlay21 - November 21, 2022

Huge News on SIE, Major Lithium Drill program to start soon.

Huge News for Sienna Resources, Government Approval for Drilling has been received for the Blue Clay Lithium Project. Drill program to...
MicroHouse221 - October 21, 2022

I bought in

I read the news from yesterday so I was watching it in the morning and decided to jump in and already made my money, I'll continue...
smallcaptdr - August 31, 2022

RE:RE:RE:RE:RE:RE:Delaware

Selling right now for a very nice short term gain Thanks!
savyinvestor333 - August 3, 2022
View more Bullboard ››

Nextech3D.ai

Nextech3D.ai

Nextech3D.ai is a diversified technology company that leverages proprietary artificial intelligence (AI) to create 3D models ...
View More »